In the European Union, TB patients from former Soviet countries have a high risk of multidrug resistance

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 9, 2006, Pages 954-958

  Falzon, Dennis ^a,b   Infuso, A ^a   Ait Belghiti F ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b NONE   (France)

Author keywords

European Union; Former Soviet Union; Multidrug resistant tuberculosis; Multivariable analysis

Indexed keywords

ADULT; AGED; ARTICLE; BALTIC STATES; CONTROLLED STUDY; EUROPEAN UNION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RISK FACTOR; TUBERCULOSIS; USSR;

ADULT; AGED; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; USSR;

EID: 33748584579     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. World Health Organization. Anti-tuberculosis drug resistance in the world. Report No 3. Prevalence and trends. WHO/HTM/TB/2004.343. Geneva, Switzerland: WHO, 2004.
2. Coker R J, Atun R A, McKee M. Health-care system frailties and public health control of communicable disease on the European Union's new eastern border. Lancet 2004; 363: 1389-1392.
3. EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2003. Saint-Maurice, France: InVS, 2003. www.eurotb.org Accessed September 2005.
4. Schwoebel V, Lambregts-van Weezenbeek C S B, Moro M L, et al. Standardisation of anti-tuberculosis drug resistance surveillance in Europe. Recommendations of a WHO and IUATLD Working Group. Eur Respir J 2000; 16: 364-371.
5. Granich R M, Oh P, Lewis B, Porco T C, Flood J. Multidrug resistance among persons with tuberculosis in California, 1994-2003. JAMA 2005; 293: 2732-2739.
6. Cox H S, Orozco J D, Male R, et al. Multidrug-resistant tuberculosis in Central Asia. Emerg Infect Dis 2004; 10: 865-872.
7. Kimerling M E, Kluge H, Vezhnina N, et al. Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis 1999; 3: 451-453.
8. Atun R A, Samyskin Y A, Drobniewski F, et al. Barriers to sustainable tuberculosis control in the Russian Federation health system. Bull World Health Organ. 2005; 83: 217-223.
9. Khan K, Muenning P, Behta M, Zivin J G. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med 2002; 347: 1850-1859.
10. Faustini A, Hall A J, Perucci C A. Risk factors for multi-drug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158-163.
11. Clark C M, Li J, Driver C R, Munsiff S S. Risk factors for drug-resistant tuberculosis among non-US-born persons in New York City. Int J Tuberc Lung Dis 2005; 9: 964-969.
12. Espinal M A, Laserson K, Camacho M, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001; 5: 887-893.